India's drug landscape is witnessing a substantial rise in drug substance companies. Fueled by rising global demand and beneficial government guidelines, the Indian API manufacturing domain has emerged as a important contributor to the worldwide healthcare network. This surge is creating several chances for investment and job creation across the co